|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/52 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3091020 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16159438.7 |
| Europos patento paraiškos padavimo data | 2010-05-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 216221 P | 2009-05-14 | US |
| (72) |
Armitage, Ian, G, US
Chopra, Reenu, GB
Cooper, Martin, Ian, GB
Langston, Marianne, US
Langston, Steven P., US
Vyskocil, Stepan, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE |
| HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE |